In the above-mentioned report utilizing anti-CTLA-4 antibodies, Faecalibacterium genus and other Firmicutes not only correlated with a good treatment outcome, but also with the frequency and severity of enterocolitis (223). This evidence concerns the gene CTLA4 and enterocolitis.